Evolving developments in the management of COPD

“The quality of what Pharmacy Management is putting on is simply streets ahead of anything else I’m seeing at the moment. Keep up the good work!”
Noel Wicks, Managing Director, Right Medicine Pharmacy Ltd, Stirling
Satellite Evolving developments in the management of COPD
Speakers Professor Dave Singh, Professor of Clinical Pharmacology and Respiratory Medicine, University Hospital Of South Manchester NHS Foundation Trust Dave Singh is professor of clinical pharmacology & respiratory medicine at the University of Manchester. He graduated from Cambridge University and then trained in clinical pharmacology and respiratory medicine in Manchester, including postgraduate research. His research interest is the development of new drugs for asthma and COPD, involving clinical trials, biomarker studies and basic mechanisms. He has over 250 publications. He is a member of the GOLD Science Committee, and the chair of the ERS airway pharmacology group. He is the medical director of the Medicines Evaluation Unit, which performs both early and late phase clinical trials.
Satellite Description

COPD guideline update

COPD Phenotypes

Pharmacological treatment update


This sponsored session is organised and funded by Chiesi Ltd

Sponsored By Chiesi Ltd

Back to Course

Connect with us Industry NHS


This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.